Atorlip 5: Effective Lipid Management for Cardiovascular Risk Reduction - Evidence-Based Review

Product Description: Atorlip 5 is a prescription medication containing the active substance atorvastatin in a dosage of 5 mg per tablet. It belongs to the pharmacological class of HMG-CoA reductase inhibitors, commonly known as statins. Its primary, evidence-based use is the reduction of elevated levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B in the blood, as an adjunct to diet, in adult patients with primary hypercholesterolemia or mixed dyslipidemia.